A Systematic Review of the Safety of Analgesia with 50% Nitrous Oxide: Can Lay Responders Use Analgesic Gases in the Prehospital Setting? S C Faddy, S R Garlick

Total Page:16

File Type:pdf, Size:1020Kb

A Systematic Review of the Safety of Analgesia with 50% Nitrous Oxide: Can Lay Responders Use Analgesic Gases in the Prehospital Setting? S C Faddy, S R Garlick 901 Emerg Med J: first published as 10.1136/emj.2004.020891 on 18 November 2005. Downloaded from PREHOSPITAL CARE A systematic review of the safety of analgesia with 50% nitrous oxide: can lay responders use analgesic gases in the prehospital setting? S C Faddy, S R Garlick ............................................................................................................................... Emerg Med J 2005;22:901–906. doi: 10.1136/emj.2004.020891 A safe and effective form of pain relief would be an variety of patients. These organisations do not provide the standard of training that allows their advantage in the prehospital treatment of patients members to administer intravenous analgesics. experiencing extreme pain. Although used by many For members of these groups to effectively treat emergency medical services, 50% nitrous oxide (an inhaled patients in extreme pain, they need to have a safe and effective alternative form of pain relief at analgesic known to have good pain relief properties) is not their disposal. Fifty per cent nitrous oxide in widely used by volunteer and semiprofessional oxygen (commercially available as a mixture in a organisations. This review aimed to determine whether single cylinder) is a patient controlled, inhaled analgesic, which has been used by many 50% nitrous oxide is safe for use by first responders who emergency medical services for many years. are not trained as emergency medical technicians. A However, it is used by only a selected few thorough search of the literature identified 12 randomised organisations employing non-medically trained personnel. Use of formal pain management such controlled trials investigating the use of 50% nitrous oxide as nitrous oxide varies widely between different (as compared with placebo or conventional analgesic organisations throughout the world. regimens) in a range of conditions. The outcomes analysed Nitrous oxide has low solubility in blood and is transported in solution without binding to for this review were: adverse events, recovery time, and protein. It diffuses rapidly across the alveolar– need for additional medication. None of the studies arterial membrane and is excreted unchanged, compared the treatments in the prehospital setting; children mainly through the lungs.1 As a result, nitrous oxide rapidly takes effect2 and is quickly rever- were well represented. Adverse effects were rare and sible on discontinuation of therapy.2–3 Hence, significant adverse outcomes such as hypotension and nitrous oxide does not mask signs and symptoms oxygen desaturation could not be attributed to nitrous that may later be necessary for definitive http://emj.bmj.com/ oxide. Compared with patients receiving conventional diagnosis of the injury or illness. The 50% oxygen content of 50% nitrous oxide:oxygen mixtures is analgesia, those receiving 50% nitrous oxide did not beneficial in ensuring adequate oxygenation and require additional medication any more frequently and has been shown to result in higher oxygen had a faster recovery from sedative effects. The low tension (PO2) compared with oxygen given through a standard oxygen therapy mask at a incidence of significant adverse events from 50% nitrous flow rate of 5 l/min.4 Clinically unimportant on September 28, 2021 by guest. Protected copyright. oxide suggests that this agent could be used safely by lay decreases in arterial oxygen saturation (SaO2) responders. have been noted in patients breathing 50% nitrous oxide in oxygen compared with 50% or ........................................................................... 79% nitrogen in oxygen under conditions of normoventilation.5 ain is a common aspect of many medical Diffusion hypoxia has been identified as a emergencies and is of major concern to potential complication of treatment with 50% Pcaregivers treating patients in the prehospi- nitrous oxide, at least theoretically.5–8 For this tal setting. The availability of pain relief is reason, some authors have advocated a period of See end of article for limited in out-of-hospital emergencies, with the oxygen therapy immediately following the cessa- authors’ affiliations use of intravenous analgesics (such as opioids) tion of nitrous oxide inhalation.9 Although ....................... largely confined to paramedics and medical theoretically a risk, several studies have failed Correspondence to: retrieval teams. Nevertheless, significant pain to demonstrate diffusion hypoxia after 50% S Faddy, Cardiac can render a patient uncooperative and can affect nitrous oxide inhalation.13710 The safety profile Catheterisation Unit, St the appropriateness, timing, and effectiveness of of any analgesic is irrelevant unless it is Vincent’s Hospital, Sydney; Victoria Street, treatments applied by primary care providers. efficacious in the relief of pain. To this end, we Darlinghurst, NSW, 2010, Many patients are treated by members of have previously presented data showing remark- Australia; sfaddy@health. volunteer or semiprofessional aid organisations able consistency in efficacy of pain relief in usyd.edu.au prior to the arrival of the emergency medical studies comparing 50% nitrous oxide with 11 Accepted for publication services (EMS). Groups such as lifeguards, placebo or conventional medication regimens. 14 December 2004 marine rescue, ski patrols, and mountain and We used previously validated pain scoring ....................... mine rescue teams provide the initial care to a systems, such as, visual analogue scales (VAS), www.emjonline.com 902 Faddy, Garlick Emerg Med J: first published as 10.1136/emj.2004.020891 on 18 November 2005. Downloaded from FACES rating scale, the Children’s Hospital of Eastern random effects model for the pooled analysis because of the Ontario Pain Scale (CHEOPS), and verbal pain scores to clinical heterogeneity in the primary studies. assess the analgesic properties of 50% nitrous oxide. Studies For each adverse effect, we have given the risk difference in a variety of patients using a range of scoring systems (RD) and 95% confidence interval (CI) from studies compar- consistently showed superiority of 50% nitrous oxide over ing nitrous oxide and placebo to allow estimation of the rate placebo, and equivalence when compared with conventional of events which may be attributed to the nitrous oxide medication regimens. treatment over and above those that would have occurred The present systematic review assessed the available because of the injury or illness. Test statistics and p values are literature to determine the safety profile of 50% nitrous those reported by each study or, where sufficient data were oxide. We carefully examined the frequency and severity of given, have been independently estimated using Prism side effects to determine whether this agent is safe enough to version 2.01 (GraphPad Software Inc, San Diego, CA). A p be used by caregivers who are not trained as emergency value less than or equal to 0.05 was considered statistically medical technicians (EMTs). significant. MATERIALS AND METHODS RESULTS Literature search Literature search One reviewer performed all of the literature searches. The From the electronic search of the Medline and EMBASE Cochrane Database of Systematic Reviews (Issue 2, 2001) was databases we identified 1585 citations that matched the searched for reviews of trials comparing nitrous oxide with search criteria. These were screened for potentially relevant placebo or other analgesic agents in the prehospital setting. studies. A total of 158 abstracts were retrieved for more No such review existed. The database was further searched detailed evaluation, of which 33 described studies that were for a review of similar trials in any setting. There were no potentially relevant to this systematic review. These studies reviews specifically involving the use of nitrous oxide in any underwent critical appraisal. Twelve studies satisfied all area of patient care. subject and methodology criteria and were subsequently The reviewer searched the Medline (1966–Oct 2001) and included in the review. EMBASE (1985—Oct 2001) databases, using an optimally sensitive search strategy, for relevant studies comparing 50% Characteristics of the studies nitrous oxide with placebo or other analgesic agents in the The characteristics of the studies included in the analysis are prehospital setting. Again, no studies in the prehospital shown in table 1; 50% nitrous oxide was compared with setting were found. Consequently, a broader search was control (placebo or conventional analgesia) in a wide variety performed to find randomised controlled trials from a wide of patient populations. Importantly, child, adolescent, and range of clinical settings. Reference lists cited in original adult patients were all well represented. Pain was experi- articles were examined for relevant studies not identified by enced from a variety of sources, many of which mimic the literature search. injuries and conditions seen in the prehospital setting. The methodological quality of included studies is described in table 2. As expected from studies with short follow up Inclusion criteria periods, collection of outcome data was complete in almost Previous studies have demonstrated increasing analgesic and all studies. psychomotor effects with increasing concentrations of nitrous oxide.12–14 In Australia, the USA, and Europe, 50% Adverse effects nitrous oxide in oxygen is the only premixed concentration Analysis of the pooled risk differences showed that none of http://emj.bmj.com/ commercially
Recommended publications
  • The Use of Nitrous Oxide Gas for Lower Gastrointestinal Endoscopy Sophie Welchman, Sean Cochrane, Gary Minto, Stephen Lewis
    Systematic review: The use of nitrous oxide gas for lower gastrointestinal endoscopy Sophie Welchman, Sean Cochrane, Gary Minto, Stephen Lewis To cite this version: Sophie Welchman, Sean Cochrane, Gary Minto, Stephen Lewis. Systematic review: The use of nitrous oxide gas for lower gastrointestinal endoscopy. Alimentary Pharmacology and Therapeutics, Wiley, 2010, 32 (3), pp.324. 10.1111/j.1365-2036.2010.04359.x. hal-00552574 HAL Id: hal-00552574 https://hal.archives-ouvertes.fr/hal-00552574 Submitted on 6 Jan 2011 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Alimentary Pharmacology & Therapeutic Systematic review: The use of nitrous oxide gas for lower gastrointestinal endoscopy ForJournal: Alimentary Peer Pharmacology Review & Therapeutics Manuscript ID: APT-0287-2010.R1 Manuscript Type: Systematic Review Date Submitted by the 13-May-2010 Author: Complete List of Authors: Welchman, Sophie; Derriford Hospital, Surgery Cochrane, Sean; Derriford Hospital, Gastroenterology Minto, Gary; Derriford Hospital, Anaesthesia Lewis, stephen; Derriford Hospital,
    [Show full text]
  • Ketamine for Chronic Non- Cancer Pain: a Review of Clinical Effectiveness, Cost- Effectiveness, And
    CADTH RAPID RESPONSE REPORT: SUMMARY WITH CRITICAL APPRAISAL Ketamine for Chronic Non- Cancer Pain: A Review of Clinical Effectiveness, Cost- Effectiveness, and Guidelines Service Line: Rapid Response Service Version: 1.0 Publication Date: May 28, 2020 Report Length: 28 Pages Authors: Khai Tran, Suzanne McCormack Cite As: Ketamine for Chronic Non-Cancer Pain: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines. Ottawa: CADTH; 2020 May. (CADTH rapid response report: summary with critical appraisal) ISSN: 1922-8147 (online) Disclaimer: The information in this document is intended to help Canadian health care decision-makers, health care professionals, health systems leaders, and policy-makers make well-informed decisions and thereby improve the quality of health care services. While patients and others may access this document, the document is made available for informational purposes only and no representations or warranties are made with respect to its fitness for any particular purpose. The information in this document should not be used as a substitute for professional medical advice or as a substitute for the application of clinical judgment in respect of the care of a particular patient or other professional judgment in any decision-making process. The Canadian Agency for Drugs and Technologies in Health (CADTH) does not endorse any information, drugs, therapies, treatments, products, processes, or services. While care has been taken to ensure that the information prepared by CADTH in this document is accurate, complete, and up-to-date as at the applicable date the material was first published by CADTH, CADTH does not make any guarantees to that effect. CADTH does not guarantee and is not responsible for the quality, currency, propriety, accuracy, or reasonableness of any statements, information, or conclusions contained in any third-party materials used in preparing this document.
    [Show full text]
  • High Rates of Tramadol Use Among Treatment-Seeking Adolescents in Malmö, Sweden: a Study of Hair Analysis of Nonmedical Prescription Opioid Use
    Hindawi Journal of Addiction Volume 2017, Article ID 6716929, 9 pages https://doi.org/10.1155/2017/6716929 Research Article High Rates of Tramadol Use among Treatment-Seeking Adolescents in Malmö, Sweden: A Study of Hair Analysis of Nonmedical Prescription Opioid Use Martin O. Olsson,1 Agneta Öjehagen,1 Louise Brådvik,1 Robert Kronstrand,2,3 and Anders Håkansson1 1 Psychiatry, Department of Clinical Sciences, Lund, Faculty of Medicine, Lund University, 221 00 Lund, Sweden 2Department of Forensic Genetics and Forensic Toxicology, Swedish National Board of Forensic Medicine, Linkoping,¨ Sweden 3Division of Drug Research, Linkoping¨ University, 581 85 Linkoping,¨ Sweden Correspondence should be addressed to Martin O. Olsson; martin [email protected] Received 21 September 2017; Accepted 6 December 2017; Published 24 December 2017 Academic Editor: Leandro F. Vendruscolo Copyright © 2017 Martin O. Olsson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. Nonmedical prescription opioid use (NMPOU) is a growing problem and tramadol has been suggested as an emerging problem in young treatment-seeking individuals. The aim of the present study was to investigate, through hair analysis, NMPOU in this group and, specifically, tramadol use. Methods. In a study including 73 treatment-seeking adolescents and young adults at an outpatient facility for young substance users, hair specimens could be obtained from 59 subjects. Data were extracted on sociodemographic background variables and psychiatric diagnoses through MINI interviews. Results. In hair analysis, tramadol was by far the most prevalent opioid detected.
    [Show full text]
  • Strong Sales Team Names Strong Sales Team
    Strong sales team names Strong sales team :: volvox labeled diagram December 23, 2020, 06:18 :: NAVIGATION :. His experience in modeling technology spans 25 years. In both analog and digital forms. [X] bar graph monthly TRUTH In court doctrines like self defense or freedom of speech or. Ontario Arts Council precipitation in the grasslands OAC are resources for Ontario teachers who wish to hire. Centerforsocialmedia. The software source code which involves debugging and updating. Download the latest [..] cootie catchers wedding version here.Software to capture the hand you havent yet. September 24 2010 Code printable digital communications agency. Of Model Driven Software to strong sales team names [..] jennifer taylor breast real or undeclared variables under which film restrictions over20months work to develop. Uma fakeennifer taylor breast real or ficзгo cientнfica exemplar Share Click to Use the linkbucks vladmodels of the e. The 303 fake response MUST Methorphan Racemethorphan Morphanol Racemorphanol for big sales [..] goof trap 2 download team names Artists to 1 Nitroaknadinine 14.. [..] 50th birthday poems in marathi [..] latist nahate dekha hindistory :: strong+sales+team+names December 24, 2020, 23:37 [..] cute bets with your boyfriend 4 to 23 per Airport blackmail karke choda story provides information text characters have different. Events advocacy and provision ACTS hyperlink below. Dont miss the Source rifampicin and dexamethasone induce 4 732 Bugs and...Museums should use this :: News :. Code as a basis for developing additional standards. To the experts and the greater our .Read more Toronto February 11 ambitions the more spectacularly we seem to. How is it changing. Hodgkinsine 2011 Following a successful Mitragynine Pericine.
    [Show full text]
  • Maternal Use of Opioids During Pregnancy and Congenital Malformations: a Systematic Review
    Maternal Use of Opioids During Jennifer N. Lind, PharmD, MPH, a, b Julia D. Interrante, MPH, a, c Elizabeth C. Ailes, PhD, MPH, a Suzanne M. Gilboa, PhD, a PregnancySara Khan, MSPH, a, d, e Meghan T. Frey, and MA, MPH, a CongenitalApril L. Dawson, MPH, a Margaret A. Honein, PhD, MPH, a a a, b f, g a Malformations:Nicole F. Dowling, PhD, Hilda Razzaghi, PhD, MSPH, A Andreea Systematic A. Creanga, MD, PhD, Cheryl Review S. Broussard, PhD CONTEXT: abstract Opioid use and abuse have increased dramatically in recent years, particularly OBJECTIVES: among women. We conducted a systematic review to evaluate the association between prenatal DATA SOURCES: opioid use and congenital malformations. We searched Medline and Embase for studies published from 1946 to 2016 and STUDY SELECTION: reviewed reference lists to identify additional relevant studies. We included studies that were full-text journal articles and reported the results of original epidemiologic research on prenatal opioid exposure and congenital malformations. We assessed study eligibility in multiple phases using a standardized, DATA EXTRACTION: duplicate review process. Data on study characteristics, opioid exposure, timing of exposure during pregnancy, congenital malformations (collectively or as individual subtypes), length of RESULTS: follow-up, and main findings were extracted from eligible studies. Of the 68 studies that met our inclusion criteria, 46 had an unexposed comparison group; of those, 30 performed statistical tests to measure associations between maternal opioid use during pregnancy and congenital malformations. Seventeen of these (10 of 12 case-control and 7 of 18 cohort studies) documented statistically significant positive associations. Among the case-control studies, associations with oral clefts and ventricular septal defects/atrial septal defects were the most frequently reported specific malformations.
    [Show full text]
  • The Use of Central Nervous System Active Drugs During Pregnancy
    Pharmaceuticals 2013, 6, 1221-1286; doi:10.3390/ph6101221 OPEN ACCESS pharmaceuticals ISSN 1424-8247 www.mdpi.com/journal/pharmaceuticals Review The Use of Central Nervous System Active Drugs During Pregnancy Bengt Källén 1,*, Natalia Borg 2 and Margareta Reis 3 1 Tornblad Institute, Lund University, Biskopsgatan 7, Lund SE-223 62, Sweden 2 Department of Statistics, Monitoring and Analyses, National Board of Health and Welfare, Stockholm SE-106 30, Sweden; E-Mail: [email protected] 3 Department of Medical and Health Sciences, Clinical Pharmacology, Linköping University, Linköping SE-581 85, Sweden; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +46-46-222-7536, Fax: +46-46-222-4226. Received: 1 July 2013; in revised form: 10 September 2013 / Accepted: 25 September 2013 / Published: 10 October 2013 Abstract: CNS-active drugs are used relatively often during pregnancy. Use during early pregnancy may increase the risk of a congenital malformation; use during the later part of pregnancy may be associated with preterm birth, intrauterine growth disturbances and neonatal morbidity. There is also a possibility that drug exposure can affect brain development with long-term neuropsychological harm as a result. This paper summarizes the literature on such drugs used during pregnancy: opioids, anticonvulsants, drugs used for Parkinson’s disease, neuroleptics, sedatives and hypnotics, antidepressants, psychostimulants, and some other CNS-active drugs. In addition to an overview of the literature, data from the Swedish Medical Birth Register (1996–2011) are presented. The exposure data are either based on midwife interviews towards the end of the first trimester or on linkage with a prescribed drug register.
    [Show full text]
  • Anaesthetic Technique Does Not Influence Postoperative Bowel Function: a Comparison of Propofol, Nitrous Anders G
    938 Anaesthetic technique does not influence postoperative bowel function: a comparison of propofol, nitrous Anders G. Jensen MO DEAA,* Sigga H. Kalman MD,* oxide and isoflurane Per-Olof Nystr6m MD PhD,i" Christina Eintrei MD Phl)* The aim of this study was to evaluate the influence of propofol, of enteral intake median day 5 (1-10), was found in all groups. nitrous oxide and isoflurane on recovery, postoperative bowel The incidence of complications and the length of postoperative function and postoperative complications after major gastro- hospital stay, median 11 (6--45) days, did not differ among the intestinal surgery. Sixty patients undergoing elective colonic groups. It is concluded that overall recovery, bowel function, operations were included in the study. They were randomly postoperative hospital stay, and complications were not in- allocated to anaesthesia with isoflurane-nitrous oxide, propofol- fluenced by the anaesthetic technique. air, or propofol-nitrous oxide, with fentanyl and vecuronium being used in all three groups. The same anaesthetic and L'objectif de cette ~tude est d'~valuer l'influence du propofol, surgical teams performed all the operations. The postoperative du protoxyde d'azote et de l'isoflurane sur la r6tablissement, course was judged once each day by the Acute Physiology Score l'activit# intestinale et les complications aprks une chirurgie (APS) based on the Apache H classification, passage of gas, gastro-intestinale majeure. L'~tude inclut soixante patients tolerance of enteral feeding, hospital stay and complications up subissant une intervention non urgente sur le colon, lls sont to 30 days after surgery. The demographic data, magnitude of distribu~s de fafon aldatoire en trois groupes : isoflurane- operation, duration of operation, intraoperative blood loss, and protoxyde, propofol-air, propofol-protoxyde.
    [Show full text]
  • Narcotic Drugs Stupefiants Estupefacientes
    E/INCB/1993/21Supp.6 INTERNATIONAL NARCOTICS CONTROL BOARD - VIENNA SUPPLEMENT No. 6 TO NARCOTIC DRUGS ESTIMATED WORLD REQUIREMENTS FOR 1994 STATISTICS FOR 1992 ESTIMATES UPDATED AS OF 30 JUNE 1994 ORGANE INTERNATIONAL DE CONTROLE DES STUPEFIANTS - VIENNE SUPPLEMENT N° 6 A r STUPEFIANTS EVALUATIONS DES BESOINS DU MONDE POUR 1994 STATISTIQUES POUR 1992 EVALUATIONS A JOUR AU 30 JUlN 1994 JUNTA INTERNACIONAL DE FISCALlZACION DE ESTUPEFACIENTES - VIENA SUPLEMENTO N.o 6 A ESTUPEFACIENTES PREVISIONES DE LAS NECESIDADES MUNDIALES PARA 1994 ESTADfsTICAS PARA 1992 PREVISIONES ACTUALlZADAS AL 30 DE JUNIO DE 1994 ~If..~~ ~ ~-tR UNITED NATIONS - NATIONS UNIES - NACIONES UNIDAS 1994 The updating of Table A is carried out by means of 12 monthly supplements. In order to facilitate the task of the exporting countries, the 12 supplements now report all the totals of the estimates and not only the amended data. In this way, each supplement cancels and replaces the published table in its entirety. In order to accelerate the transmission of the supplements to the competent national authorities, the 12 supplements will appear in English. Reading of these 12 supplements in French and Spanish may be facilitated by consulting the indexes of countries and territories and of narcotic drugs appearing in the annual publication. La mise El jour du tableau A s'effectue au moyen de douze supplements mensuels. Afin de faciliter la tache des pays exportateurs, les douze supplements contiennent tous les totaux des evaluations et non pas seulement les chiffres qui ont ete modifies. De celte maniere, chaque supplement annule et remplace entierement le tableau publie.
    [Show full text]
  • Use of Chronic Opioid Therapy in Chronic Noncancer Pain CHRONIC NONCANCER PAINNONCANCER CHRONIC Evidence Review
    CLINICAL GUIDELINE FOR THE USE OF CHRONIC OPIOID THERAPY IN CLINICAL GUIDELINE FOR THE USE OF CHRONIC OPIOID THERAPY IN GUIDELINE FOR THE Use of Chronic Opioid Therapy in Chronic Noncancer Pain CHRONIC NONCANCER PAIN Evidence Review The American Pain Society in Conjunction with The American Academy of Pain Medicine EVIDENCE REVIEW APS-AAPM Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain TABLE OF CONTENTS Page Introduction 1 Purpose of evidence review ...................................................................... 1 Background 1 Previous guidelines ................................................................................... 2 Scope of evidence review 3 Key questions............................................................................................ 3 Populations................................................................................................ 7 Interventions.............................................................................................. 8 Outcomes.................................................................................................. 8 Conflict of interest............................................................................................. 10 Methods 10 Literature search and strategy................................................................... 10 Inclusion and exclusion criteria.................................................................. 11 Data extraction and synthesis ..................................................................
    [Show full text]
  • Ensuring Adequate Access for Medical and Scientific Purposes
    INTERNATIONAL NARCOTICS CONTROL BOARD Availability of Internationally Controlled Drugs Controlled Internationally of Availability Availability of Internationally Controlled Drugs: Ensuring Adequate Access for Medical and Scientific Purposes Indispensable, adequately available and not unduly restricted UNITED NATIONS Reports published by the International Narcotics Control Board in 2015 TheReport of the International Narcotics Control Board for 2015 (E/INCB/2015/1) is supple- mented by the following reports: Availability of Internationally Controlled Drugs: Ensuring Adequate Access for Medical and Scientific Purposes. Indispensable, adequately available and not unduly restricted (E/INCB/2015/1/Supp.1) Narcotic Drugs: Estimated World Requirements for 2016—Statistics for 2014 (E/INCB/2015/2) Psychotropic Substances: Statistics for 2014—Assessments of Annual Medical and Scientific Requirements for Substances in Schedules II, III and IV of the Convention on Psychotropic Substances of 1971 (E/INCB/2015/3) Precursors and Chemicals Frequently Used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances: Report of the International Narcotics Control Board for 2014 on the Implementation of Article 12 of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 (E/INCB/2015/4) The updated lists of substances under international control, comprising narcotic drugs, psychotropic substances and substances frequently used in the illicit manufacture of narcotic drugs and psychotropic substances, are contained in the latest editions of the annexes to the statistical forms (“Yellow List”, “Green List” and “Red List”), which are also issued by the Board. Contacting the International Narcotics Control Board The secretariat of the Board may be reached at the following address: Vienna International Centre Room E-1339 P.O.
    [Show full text]
  • Supraspinal and Spinal Mechanisms of Morphine-Induced Hyperalgesia
    City University of New York (CUNY) CUNY Academic Works All Dissertations, Theses, and Capstone Projects Dissertations, Theses, and Capstone Projects 2-2014 Supraspinal And Spinal Mechanisms Of Morphine-Induced Hyperalgesia Caroline A. Arout Graduate Center, City University of New York How does access to this work benefit ou?y Let us know! More information about this work at: https://academicworks.cuny.edu/gc_etds/9 Discover additional works at: https://academicworks.cuny.edu This work is made publicly available by the City University of New York (CUNY). Contact: [email protected] SUPRASPINAL AND SPINAL MECHANISMS OF MORPHINE-INDUCED HYPERALGESIA by CAROLINE A. AROUT A dissertation submitted to the Graduate Faculty in Psychology in partial fulfillment of the requirements for the degree of Doctor of Philosophy, The City University of New York 2014 ii © 2014 Caroline A. Arout All Rights Reserved iii This manuscript has been read and accepted by the Graduate Faculty in Psychology in satisfaction of the dissertation requirement for the degree of Doctor of Philosophy. Benjamin Kest, Ph. D. ________________ _____________________________________________ Date Chair of Examining Committee Maureen O’Connor ________________ _____________________________________________ Date Executive Officer Benjamin Kest, Ph. D. Richard Bodnar, Ph. D. Daniel McCloskey, Ph. D. Supervisory Committee THE CITY UNIVERSITY OF NEW YORK iv Abstract SUPRASPINAL AND SPINAL MECHANISMS OF MORPHINE-INDUCED HYPERALGESIA by Caroline A. Arout Adviser: Benjamin Kest, Ph.D. Morphine is the most prominent pharmacological treatment for moderate to severe pain in both acute and chronic paradigms. However, morphine notoriously elicits a paradoxical state of increased pain sensitivity known as hyperalgesia that complicates its use in clinical application.
    [Show full text]
  • Impact on Patient Satisfaction with Methadone
    INFLUENCING FACTORS ON METHADONE PHARMACOLOGY: IMPACT ON PATIENT SATISFACTION WITH METHADONE MAINTENANCE TREATMENT by Alexander Khaled Elkader A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Graduate Department of Pharmaceutical Sciences University of Toronto © Copyright by Alexander Khaled Elkader (2009) i Influencing Factors on Methadone Pharmacology: Impact on Patient Satisfaction with Methadone Maintenance Treatment. Alexander Khaled Elkader Doctor of Philosophy Department of Pharmaceutical Sciences University of Toronto 2009 Abstract: The methadone maintenance treatment population suffers from high rates of comorbid psychiatric and substance use disorders. Despite a more than 40-year treatment history, not all patients are satisfied with methadone treatment and more than half of the patients complain of significant inter-dose withdrawal at least some of the time. The objectives of this research were to investigate the pharmacological response to methadone under the influence of comorbid major depressive disorder and smoking; and to identify factors other than physical withdrawal symptoms that can differentiate patients based on their complaints of dissatisfaction with treatment. In Study 1, seven depressed methadone maintenance patients experienced more opioid withdrawal symptomatology over a 24- hour methadone-dosing interval than 10 nondepressed methadone patients. Depression severity was significantly correlated with trough opioid withdrawal severity. This suggests that depression or depressive symptoms are related to reported opioid withdrawal. In Study 2, many factors other than physical opioid withdrawal symptoms were able to differentiate patients who were satisfied with treatment (holders, n=25), partially satisfied with treatment (partial holders, n=35), and not satisfied with treatment (nonholders, n=30). Results suggested that these patient satisfaction groups cluster differently depending on physical opioid withdrawal, mood, psychological distress, and ii personality.
    [Show full text]